Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases
Abstract Background In limited metastatic burden of disease, stereotactic body radiotherapy (SBRT) has been shown to achieve high local control rates. It has been hypothesized that SBRT may translate to a better quality of life by delaying the need for systemic chemotherapy and possibly increasing s...
Main Authors: | Rosanna Yeung, Jeremy Hamm, Mitchell Liu, Devin Schellenberg |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-06-01
|
Series: | Radiation Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13014-017-0820-1 |
Similar Items
-
Stereotactic Body Radiotherapy for Patients with Lung Oligometastatic Disease: A Five-Year Systematic Review
by: Guillaume Virbel, et al.
Published: (2021-07-01) -
Editorial: Novel Applications of Stereotactic Body Radiotherapy (SBRT)
by: Rupesh Kotecha, et al.
Published: (2021-09-01) -
Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Lung Nodules: A Single Institution Series
by: Rodney E. Wegner, et al.
Published: (2019-05-01) -
Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease
by: Sabine Gerum, et al.
Published: (2018-05-01) -
Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview
by: Kang Liang Zeng, et al.
Published: (2019-05-01)